Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Edward Romond MD
To assess the safety and efficacy of the combination of Herceptin and chemotherapy in the treatment of 2700 node-positive breast cancer patients whose tumors overexpress the HER2 protein or demonstrate evidence of HER2 gene-amplification.
Node-positive breast cancer patients who have tumors that overexpress HER2
Protocol Record Retention DatesDate Records No Longer to be Kept by US Sites: 03/31/2023Date Records No Longer to be kept by Canadian Sites: 03/31/2045Date Records for B-31.1 No Longer to be kept by Canadian Sites: 03/31/2023
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.